Revolution Medicines, Inc. (RVMD) Misses Q3 EPS by 5c

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q3 EPS of ($0.94), $0.05 worse than the analyst estimate of ($0.89). Revenue for the quarter came in at $0 versus the consensus estimate of $807.69 thousand.

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• Anthropic Expected to Tell Investors It Sees a More Than $30T Total Addressable Market - WSJ
• Photronics, Inc. (PLAB) call put ratio 5 calls to 1 put into quarter results
• J. M. Smucker (SJM) call put ratio 1 call to 1.1 puts into quarter results